Naslov
Low back pain – what is the evidence for conservative treatments

Autori
Grazio, Simeon

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni

Izvornik
Clinical and experimental Rheumatology / - , 2009, 725-725

Skup
XIII Mediterranean Congrss of Rheumatology

Mjesto i datum
Cavtat, Hrvatska, 18.11.2009. - 21.11.2009

Vrsta sudjelovanja
Poster

Vrsta recenzije
Nije recenziran

Ključne riječi
nema dostupnih podataka

Sažetak
Low back pain (LBP) is most common reason for the limitation of activity in younger population and the most frequent cause of absence from work. Prominent treatment goals in the menagement of LBP are: reduction of pain, better activity/participation, prevention of disability and maintenance of work capacity. There is pletora of different interventions and not a single one seems to have a strong impact. For people with acute LBP fitness programmes, education programs and advice to stay active can improve/maintain function and prevent back pain becoming a chronic condition. Simple analgesics, non-steroidal anti-inflammatory drugs (NSAIDs) and muscle relaxants (for acute LBP) can reduce pain and improve and maintain function , while tricyclic antidepressants (for chronic LBP) are effective for short-term pain relief. Opioids, benzodiazepins, and gabapentin (for radiculopathy) are effective, too. Overall, the magnitude of benefit is small and evidence is insufficient to identify one medicationas offering a clear advantage. For acute LBP nonpharmacologic therapies with evidence of efficacy are superficial heat and spinal manipulation, while for chronic or subacute LBP are exercise therapy, acupuncture, massage therapy, spinal manipulation and yoga.Moreover, in chronic LBP intensive multidisciplinary treatment strategies therapy incorporating multiple treatment components, such as intensive physical exercises and biopsychosocial and behavioral interventions, are effective in reducing pain and improving function. Classifying patients with LBP into subgroups based on signs and symptoms and designing treatments based on these subgroups has been associated with better outcomes, although the dana regarding recommandations for specific therapy is still scarce. So far no intervention has been developed for which there is strong, consistent, and convincing evidence for relevantgeneral effectivness and benefit. The main problem in designing, analyzing, and appraising any study with LBP is that we still do not have a comparator of reliable (in)effectivness.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA